Unraveling the FGFR–RNA splicing axis: Mechanisms, oncogenic crosstalks and innovations for therapeutic purpose

Xuquan Xian, Ruyi Gong, Shunzi Rong, Zhihao Zhang, Fengtong Jia, Lin Li, Zhengguo Chen, Beatrice Eymin and Tao Jia

Acta Pharmaceutica Sinica B, 2026, 16, 35
DOI: 10.1016/j.apsb.2025.11.031

CRISPR/Cas12a coupled with enzyme-DNA molecular switch photoelectrochemical assay for HIV nucleic acid

Lilin Qin, Fangxu Lou, Yan Wang, Yinhao Zhang, Shishi Liu and Xu Hun

Microchemical Journal, 2023, 190, 108713
DOI: 10.1016/j.microc.2023.108713

CRISPR-integrated metal-organic frameworks for biosensing applications: Recent advances and future perspective

Babak Mikaeeli Kangarshahi, Anahita Beigi Javazm and Seyed Morteza Naghib

Sensing and Bio-Sensing Research, 2025, 47, 100736
DOI: 10.1016/j.sbsr.2025.100736

Off-target effects in CRISPR/Cas9 gene editing

Congting Guo, Xiaoteng Ma, Fei Gao and Yuxuan Guo

Front. Bioeng. Biotechnol., 2023, 11
DOI: 10.3389/fbioe.2023.1143157

Optimizing CRISPR/Cas9 precision: Mitigating off-target effects for safe integration with photodynamic and stem cell therapies in cancer treatment

J.P. Jose Merlin and Heidi Abrahamse

Biomedicine & Pharmacotherapy, 2024, 180, 117516
DOI: 10.1016/j.biopha.2024.117516

Protection of animals against devastating RNA viruses using CRISPR-Cas13s

Adnan Asadbeigi, Mohammad Reza Bakhtiarizadeh, Mojtaba Saffari, Mohammad Hossein Modarressi, Naser Sadri, Zahra Ziafati Kafi, Hassan Fazilaty, Arash Ghalyanchilangeroudi and Hossein Esmaeili

Molecular Therapy - Nucleic Acids, 2024, 35, 102235
DOI: 10.1016/j.omtn.2024.102235

Development of New Genome Editing Tools for the Treatment of Hyperlipidemia

Giulio Preta

Cells, 2023, 12, 2466
DOI: 10.3390/cells12202466

The Advancements of Nanobiotechnology in Novel Drug Delivery System: Current Trends and Future Directions

Alebachew Molla

IJBSE, 2025, 13, 57
DOI: 10.11648/j.ijbse.20251303.12

Biomimetic oral drug delivery: Translating nature’s design into therapeutic innovation

Muzaffaruddin Ahmed Madny and Khushwant S. Yadav

Colloids and Surfaces B: Biointerfaces, 2026, 259, 115348
DOI: 10.1016/j.colsurfb.2025.115348

Nanopuncturing‐Enabled Efficient Gene Editing for Isogenic Human iPSC‐Derived Organoid Engineering

Muhammad Waseem Ghani, Yutong Kong, Ambreen Iqbal, Weidong Shao, Deyuan Yang, Gaole Dai, Yuan Wang, Lei Qiu, Xiaoliang Yang, Chunyan Li, Na Sun, Zixun Wang and Renjun Pei

Adv Funct Materials, 2026, 36
DOI: 10.1002/adfm.202523579

Nanomaterials-assisted gene editing and synthetic biology for optimizing the treatment of pulmonary diseases

Lanjie Lei, Wenjie Pan, Xin Shou, Yunyuan Shao, Shuxuan Ye, Junfeng Zhang, Narasaiah Kolliputi and Liyun Shi

J Nanobiotechnol, 2024, 22
DOI: 10.1186/s12951-024-02627-w

Electroporation combined with intelligent drug delivery promising new and clean approach to cancer treatment

Sedigheh Aghayari

Results in Engineering, 2023, 19, 101379
DOI: 10.1016/j.rineng.2023.101379

CRISPR/Cas9 as a Mutagenic Factor

Andrey R. Shumega, Youri I. Pavlov, Angelina V. Chirinskaite, Aleksandr A. Rubel, Sergey G. Inge-Vechtomov and Elena I. Stepchenkova

IJMS, 2024, 25, 823
DOI: 10.3390/ijms25020823

Liposome-Based Clustered Regularly Interspaced Short Palindromic Repeats-Associated Protein Systems: Advances in Targeted Delivery and Theranostics

Yujin Kim, Gyeong-Ji Kim and Oh Seok Kwon

Appl. Sci. Converg. Technol., 2025, 34, 148
DOI: 10.5757/ASCT.2025.34.5.148

Guarding the genome: strategies for off-target detection and minimization in CRISPR/Cas9 system

Malihe Lotfi, Zahra Farshchian Yazdi, Mohammad Reza Hashemi, Mohammad Reza Abbaszadegan and Samaneh Sharif

Expert Review of Molecular Diagnostics, 2025, 25, 883
DOI: 10.1080/14737159.2025.2581677

Recent Advances in Targeted Nanocomposite-based Therapeutics for Cancer Therapy

Rashmi Pathak, Praveen Halagali, Vamshi Krishna Tippavajhala, Jagadeesh Dodakallanavar, Harish Darasaguppe Ramachandra and Himanshu Sharma

CDRR, 2025, 17, 428
DOI: 10.2174/0125899775367848250226063700

Structure-specific electrochemiluminescent biosensor for FEN1 detection via dumbbell probe-mediated transcription and CRISPR/Cas13a-induced G-quadruplexes cleavage

Zhongheng Wei, Huini Luo, Danlu Huang, Peixin Wei, Jiayi Zhang, Jihua Wei, Qianli Tang, Longjian Huang, Kai Zhang and Xianjiu Liao

Analytica Chimica Acta, 2025, 1377, 344662
DOI: 10.1016/j.aca.2025.344662

From Science to Solutions: Translating DNA‐Based Nanodevices into Clinical Applications

Anandita Chandran, Aadvik Bhardwaj, Krupa Kansara and Dhiraj Bhatia

Small, 2025, 21
DOI: 10.1002/smll.202508155

Advances in delivery systems for CRISPR/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles

Zhidu Song, Ying Tao, Yue Liu and Jian Li

Front. Immunol., 2024, 15
DOI: 10.3389/fimmu.2024.1444437